Top 50 Dna Data Storage

This startup develops an end-to-end integrated microfluidics chip that uses CRISPR-based DNA editing to write, read, and store digital data in bacterial DNA. This technology offers researchers a novel method for high-density, long-term data storage and retrieval.

This company develops IT-friendly DNA Data Storage appliances engineered for data center environments. Their modular architecture combines biosecure DNA media with industrialized end-to-end processes to create a new storage tier optimized for density and longevity. The solution offers ultra-low energy consumption at rest and high data retention for long-term archival and high-security data preservation.

Cache DNA develops next-generation biopreservation technologies to support breakthroughs in the life sciences. The company focuses on storing biomolecules at unprecedented scales, moving beyond traditional freezer storage methods. This advanced preservation supports high-quality biospecimens necessary for clinical research, assay development, and personalized therapies.

Atlas Data Storage archives digital data using synthetic DNA, offering a highly dense and stable solution for long-term preservation. This technology enables data storage for millennia with a significantly reduced physical footprint compared to traditional data centers.

The startup has developed a genome-analysis platform that facilitates the acquisition, analysis, and storage of genomic data without the need for repeated sequencing of the same genome for different tests. This technology enables healthcare providers to efficiently manage genetic data and deliver precise DNA sequencing services, enhancing the overall effectiveness of genomic research and patient care.

Genomelink allows users to upload raw DNA data from services like AncestryDNA, 23andMe, or MyHeritage for enhanced genetic analysis, providing insights into ancestry, health, and personal traits. This platform addresses the lack of detailed genetic information by offering over 350 unique traits and specialized reports that are not available through standard DNA testing services.

Zhonghe Gene develops enzyme-driven DNA biosynthesis technology, offering automated solutions for short and long-chain DNA synthesis and gene assembly. Their products enable efficient, cost-effective gene synthesis for applications in synthetic biology, biomedicine, and DNA data storage, addressing the need for accessible and scalable genetic engineering tools.

Nebula Genomics offers Whole Genome Sequencing that decodes 100% of an individual's DNA, providing comprehensive insights into health risks, ancestry, and genetic traits. Utilizing blockchain technology, the platform ensures users maintain full ownership and privacy of their genomic data while receiving regular updates based on the latest scientific research.

NextGen Jane provides a patented at‑home menstrual blood collection kit that users mail to a central lab for high‑throughput DNA/RNA sequencing. The resulting “menstrualome” profiles are linked with longitudinal health surveys and stored in a HIPAA‑compliant cloud, where anonymized data are available via API for researchers studying gynecological conditions. Participants receive periodic personal insights and can enroll in related clinical studies.

Provides a bioinformatics platform that analyzes environmental DNA (eDNA) and geospatial data to monitor and assess biodiversity. Users can run eDNA studies, upload sequence data for automated organism identification, and correlate findings with environmental variables to support conservation and management efforts.

Gene Zone operates a secure, decentralized marketplace for genetic data exchange between individuals and researchers. Data providers maintain ownership and control over their genetic information while receiving fair compensation for its use. Researchers gain streamlined access to standardized, high-quality genetic datasets to accelerate scientific discovery.

This biotechnology company is developing a novel DNA sequencing technology designed to make genomic data more accessible. Their approach aims to simplify the sequencing process, enabling broader applications of genomics.

DnaNudge utilizes DNA analysis and lifestyle data to provide personalized nutritional guidance, helping consumers make healthier food choices based on their genetic predispositions to conditions like obesity and diabetes. The company also offers a rapid, lab-free CovidNudge RT-PCR test that accurately detects COVID-19 and other viruses in under an hour, facilitating timely diagnosis without laboratory dependency.

The startup has developed a genetic engineering platform that enables long-chain DNA synthesis for the production of microbes and combinatorial DNA libraries. This technology addresses the limitations of traditional DNA synthesis methods, facilitating more efficient and scalable genetic engineering applications for medical professionals.

[Company Name] provides mobile DNA testing services for paternity, ancestry, and other familial relationship analyses. Their convenient service allows individuals to gain clarity on their heritage and family connections through a simple testing process.

The startup develops protein analysis software that utilizes reverse-translation technology to convert peptide sequences into DNA, enabling single-molecule protein sequencing. This platform provides researchers with complete proteome information at scale, facilitating more efficient protein sample analysis.

Ambient Biosciences develops a patented stabilization technology that allows temperature-sensitive biomolecules to be stored and shipped at room temperature, eliminating the need for cold chain logistics. This process significantly extends shelf life from six months to over two years while maintaining biomolecule activity, reducing waste and operational costs for laboratories.

Evonetix is developing a desktop platform that synthesizes gene-length DNA with high accuracy and scalability using a novel approach to DNA synthesis. This technology provides researchers with rapid access to precise genetic material, addressing the limitations of current gene synthesis methods that hinder innovation in healthcare and biotechnology.

Ruya AI develops advanced generative AI models focused on synthetic media creation for the entertainment industry. The platform enables studios and content creators to produce high-fidelity visual assets and digital doubles efficiently. This technology streamlines complex post-production workflows by automating aspects of character rendering and scene generation.

InsideTracker combines blood biomarker panels, DNA genotyping, fitness metrics, and lifestyle inputs into a unified health profile. Its analytics engine generates personalized nutrition, supplement, and habit recommendations, calculates an InnerAge biological‑age score, and provides an AI health assistant for real‑time guidance, with ongoing monitoring via follow‑up blood tests. The platform is delivered through a secure web and mobile dashboard on a subscription basis.

DNA-LM develops a universal language model pre-trained on diverse DNA sequences to process entire genomes. This model aims to accurately predict phenotypic traits across molecular and organism scales, reducing the need for extensive labeled data.

Elegen utilizes proprietary cell-free DNA synthesis technology to produce long, complex, linear DNA up to 7 kb with 99.999% accuracy, eliminating the need for cloning. This rapid synthesis, delivered in 6 to 8 business days, addresses the critical bottleneck in DNA supply for synthetic biology applications, significantly reducing project timelines and costs.

Many consumers lack affordable, science‑backed tools to quantify their biological age and to intervene at the cellular level, making it difficult to track aging trajectories or to apply targeted lifestyle and supplement strategies. Tally Health delivers a data‑driven longevity platform that combines a DNA‑methylation (epigenetic) test—administered via a painless cheek swab—with algorithmic age‑benchmarking and a personalized action plan. The platform prescribes monthly supplement regimens formulated to modulate key hallmarks of aging such as mitochondrial function, NAD⁺ metabolism, autophagy, and senescent‑cell clearance.

Othram utilizes proprietary KinSNP® analysis and DNASolves® database to identify human remains and resolve missing persons cases by overcoming forensic DNA barriers. The company partners with law enforcement agencies to provide in-house processing of DNA evidence, ensuring accurate identification and closure for families affected by unresolved cases.

The startup develops a DNA sequencing technology that enhances the resolution and accuracy of next-generation sequencing platforms by increasing effective read lengths and converting short-read sequencers into virtual long-read sequencers. This technology enables healthcare professionals to obtain finished-quality genome assemblies with highly accurate long DNA sequences at significantly lower costs.

Orlance develops powdered, needle-free nucleic acid vaccines (DNA and RNA) that are shelf-stable and do not require cold chain logistics. This technology addresses the challenges of vaccine distribution and administration, making it easier to deliver effective therapeutic and preventive solutions for a wide range of viral infections.

This company utilizes epigenetic and DNA testing to develop personalized longevity programs for improved healthspan. They offer tailored therapy plans supported by high-tech infusions, custom enzyme and micronutrient supplements, and longevity retreats. The core value is translating genetic insights into actionable, science-based interventions for a healthier, longer life.

LinkZill offers Thin-Film Transistor (TFT) semiconductor technology solutions for optoelectronics and life sciences. They provide standardized TFT products and custom design services for display and sensing applications, alongside a TFT-based DNA synthesizer and oligo microarrays for synthetic biology, drug discovery, and diagnostics.

Twist Bioscience offers a semiconductor-based DNA synthesis platform for high-throughput, cost-effective production of custom DNA. Their technology enables rapid generation of genes, oligo pools, and variant libraries, accelerating research in synthetic biology, drug discovery, and diagnostics.

AtomICs utilizes small molecules for data storage, achieving up to 100 million times denser storage than conventional methods while maintaining data integrity at room temperature. This technology addresses the limitations of current storage solutions, which require strict environmental controls and frequent data rewriting due to degradation.

Cerabyte develops Ceramic Nano Memory technology to provide extremely long-term, low-cost archival data storage solutions. This technology addresses the longevity and energy consumption challenges associated with traditional secondary storage media. The platform enables data retention for up to 100 years without media replacement or energy use, significantly lowering total cost of ownership for massive datasets.

The startup offers a microbiome testing service that utilizes a stool sample analysis conducted in a certified laboratory to assess gut health in infants. By providing detailed results and facilitating connections with dieticians, the service enables parents to create personalized dietary plans while ensuring data anonymity for broader health insights.

Provides a genetically personalized meal shake by analyzing DNA and methylation data to tailor nutrient profiles, ensuring individuals receive up to 15 times the recommended daily values of essential vitamins and minerals they uniquely require. This approach addresses widespread nutrient deficiencies, supports optimal health, and promotes benefits like improved recovery, immune function, and cognitive performance.

The startup develops a data conversion and storage platform that encodes digital information into deoxyribonucleic acid (DNA) format, providing a long-term archival solution. This technology enables customers to economically store vast amounts of data in DNA molecules, addressing the limitations of traditional digital storage methods.

This startup develops DNA technology tailored for synthetic biology applications, providing high-throughput libraries and custom DNA sequences for genome construction and data storage. Their services enable researchers and companies to efficiently create and manipulate DNA without facing economic or time constraints.

SelfDecode utilizes patent-pending genetic analysis technology to provide personalized health reports based on users' genomic data, enabling them to understand their genetic predispositions and optimize their wellness. The platform offers actionable insights and recommendations tailored to individual health risks, helping users make informed decisions about their health and lifestyle.

Evogenom offers an at‑home saliva DNA test that analyzes over 70 genetic markers related to metabolism, muscle composition, sleep, stress response and hormone balance. The resulting profile powers an AI‑driven mobile coach, EvoCoach, which delivers daily, personalized recommendations for nutrition, exercise, sleep and supplements, with modular add‑on programs available without re‑sampling. All data are stored securely in a GDPR‑compliant EU cloud and the service updates recommendations as users log lifestyle data.

Haelixa utilizes patented DNA technology to mark and trace raw materials throughout the supply chain, ensuring product authenticity and compliance with due diligence regulations. This solution addresses the lack of transparency in supply chains, mitigating risks associated with material substitutions, counterfeits, and regulatory non-compliance.

Geneyx provides DNA and RNA data analysis and interpretation for whole genome sequencing (WGS), whole exome sequencing (WES), gene panels, and microarrays, enabling rapid transformation of raw genetic data into clinical reports. The platform enhances diagnostic accuracy and efficiency, aiming to eliminate undiagnosed diseases by increasing the diagnostic yield and reducing turnaround times for genetic testing.

Macromo offers a mobile app that delivers AI-driven health insights, personalized consultations, and recurring at-home health tests. This integrated platform helps users understand and improve their health through data analysis and professional guidance.

The startup operates a diagnostics laboratory specializing in genetic testing, focusing on DNA and RNA extraction, sequencing, and genotyping. By providing precise sample analysis and reporting, it enables clinical and medical research enterprises to efficiently access critical genetic information for product development.

Switchback Systems has developed a scalable benchtop DNA synthesis platform that integrates oligonucleotide synthesis and gene assembly capabilities, significantly reducing the time, cost, and waste associated with traditional DNA synthesis methods. This technology empowers scientists across various industries, including pharmaceuticals and agriculture, to efficiently produce custom DNA sequences for research and development.

Genomes.io provides a secure platform for individuals to upload their genomic data and retain ownership while enabling pharmaceutical and research organizations to access this data for studies through a blockchain-based consent system. This approach addresses the lack of transparency and equitable compensation in the genomics market, allowing users to monetize their DNA data while maintaining privacy and control.

Kern Systems develops a DNA data storage platform that utilizes synthetic DNA molecules and enzymes to create a scalable, cold storage solution for unstructured data. This technology addresses the growing demand for data storage by offering a medium that is denser, more durable, and energy-efficient compared to traditional storage methods.

GenoPalate utilizes genetic analysis of over 150 markers, along with demographic and lifestyle data, to provide personalized nutrition recommendations aimed at optimizing metabolic health. By delivering tailored dietary insights, the platform helps individuals understand their unique nutritional needs and make informed food choices.

GenomSys provides a cloud-based genomic data analysis platform utilizing the ISO/IEC 23092 MPEG-G standard, enabling rapid processing and transmission of genomic files with up to 77% reduced file sizes. This technology facilitates faster time-to-market for genomic applications by streamlining workflows and enhancing data accessibility for healthcare professionals.

This startup offers whole genome sequencing technology that analyzes 100% of an individual's DNA, providing detailed insights into health risks, medication responses, and nutritional needs. By delivering personalized reports based on genetic data, the company empowers users to make informed health decisions and improve their overall well-being.

GoodCell is a biotechnology company specializing in the personal biobanking of stem cells, plasma, and DNA, along with diagnostic genetic screening. This service provides individuals with secure storage of their biological materials for potential future medical use, addressing the need for personalized health management and regenerative therapies.

Ribbon Biolabs utilizes algorithm-driven technology to synthesize pristine synthetic DNA molecules, producing linear DNA up to 12 kb and plasmids up to 20 kb with high accuracy and complexity. This addresses the critical demand for longer and more complex synthetic DNA that existing technologies fail to deliver, enabling advancements in various sectors of synthetic biology.

The startup specializes in DNA sequencing technologies, offering short-read sequencers that deliver ultra-long-range results for diploid genomes of various sizes. This capability enables precise applications such as de novo sequencing and structural variation detection, allowing businesses to efficiently generate customizable sequencing libraries tailored to their specific genomic needs.